Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03976297 · ClinicalTrials.gov registry record · NA
Artificial Intelligence/Machine Learning Modeling on Time to Palliative Care Review in an Inpatient Hospital Population
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,231
- Enrollment target
NCT03976297: Completed NA study, sponsored by Mayo Clinic.
NCT03976297 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,231 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03976297, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,231 participants
- Enrollment target
Study Summary
Investigators are testing whether machine learning prediction models integrated into a health care model will accurately identify participants who may benefit from a comprehensive review by a palliative care specialist, and decrease time to receiving a palliative care consult in an inpatient setting.
Primary Outcome
Measured as time in hours to the electronic record of consult by the palliative care team in the inpatient setting.
Interventions
- OTHER Control Tower
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,231 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2020-12-20 |
| Phase | NA |
What the finished NCT03976297 record still lists
NCT03976297 is an interventional study that assigns participants to a tested intervention. Its 2,231 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% higher).
The record links to 0 conditions, and to 1 intervention - of which Control Tower is the first listed.
NCT03976297 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03976297 about?
NCT03976297 is a clinical study titled "Artificial Intelligence/Machine Learning Modeling on Time to Palliative Care Review in an Inpatient Hospital Population". Investigators are testing whether machine learning prediction models integrated into a health care model will accurately identify participants who may benefit from a comprehensive review by a palliative care specialist, and decrease time to receiving a palliative care consult in an inpatient setting...
What is the current status of trial NCT03976297?
This trial is currently completed. It is a NA study. The enrollment target is 2,231 participants. The study started on 2019-08-19. Estimated completion is 2020-12-20.
What interventions are being tested in trial NCT03976297?
The interventions under investigation include: Control Tower (OTHER).
Who is sponsoring clinical trial NCT03976297?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03976297's enrollment target sits among peer trials
2,231 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI